Clinical Trials Logo

MV(Mitral Valve) Repair clinical trials

View clinical trials related to MV(Mitral Valve) Repair.

Filter by:
  • None
  • Page 1

NCT ID: NCT03244319 Completed - Clinical trials for MV(Mitral Valve) Repair

Explore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)

Start date: December 1, 2017
Phase: Phase 3
Study type: Interventional

1. objectives: The primary aim of ENAVLE is to explore the efficacy of edoxaban in patients with post mitral valve repair or bioprosthetic valve implantation 2. Primary / Secondary Endpoint 1) Efficacy Endpoint Evaluation: Occurrence of thromboembolic events and any thrombus at repaired ring or bioprosthetic valves detected by follow up echocardiography or 3D CT scan 2) Safety Endpoint Evaluation - Dysfunction of treated valve caused by thrombosis on echocardiography or 3D CT scan - Major or minor bleeding described in safety outcomes